Regeneron Expects Zero Covid Antibody Sales For The First Quarter Of 2022 0 04.02.2022 19:37 Forbes.com The company’s antibody therapy has been determined to be ineffective against the omicron variant that now dominates Covid-19 cases worldwide. Партнёры Smi24.net Все новости за 24 часа Музыкальные новости Агрегатор новостей 24СМИ
